124 related articles for article (PubMed ID: 2837373)
41. [Immunoperoxidase demonstration of papillomavirus antigen in dysplasia of the uterine cervix].
Toki T; Oikawa N; Tase T; Wada Y; Yajima A; Suzuki M; Higashiiwai H
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):411-5. PubMed ID: 2984298
[TBL] [Abstract][Full Text] [Related]
42. Lectin cytochemistry in the exfoliative cytology of uterine cervix.
Remani P; Pillai KR; Haseenabeevi VM; Ankathil R; Bhattathiri VN; Nair MK; Vijayakumar T
Neoplasma; 1994; 41(1):39-42. PubMed ID: 8202194
[TBL] [Abstract][Full Text] [Related]
43. Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison.
Dale GE; Coleman RM; Best JM; Benetato BB; Drew NC; Chinn S; Papacosta AO; Nahmias AJ
Epidemiol Infect; 1988 Jun; 100(3):445-65. PubMed ID: 2837405
[TBL] [Abstract][Full Text] [Related]
44. HSV 2-associated antigens in human cervical tissues before and after grafting in nude mice.
Christenson B; Furgyik S
Acta Obstet Gynecol Scand; 1983; 62(5):461-6. PubMed ID: 6320579
[TBL] [Abstract][Full Text] [Related]
45. [Cervical condyloma and dysplasia: histological and virological correlation apropos of 100 cases].
Guillet G; Braun L; Shah K; Ferenczy A
Ann Dermatol Venereol; 1983; 110(1):43-51. PubMed ID: 6305251
[TBL] [Abstract][Full Text] [Related]
46. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
Thankamani V; Kumari TV; Vasudevan DM
J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
[TBL] [Abstract][Full Text] [Related]
47. Replication of Herpes simplex virus type 2 in normal dysplastic and neoplastic human cervical epithelia.
Mandeville R; Holloway A; Lauchlan SC; Simard R
Eur J Cancer (1965); 1979 Mar; 15(3):351-61. PubMed ID: 221223
[No Abstract] [Full Text] [Related]
48. [Human papillomavirus infections of the cervix uteri. Clinical implications, indications of typing].
Laval C; Le Doussal V; Pratili M
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):803-10. PubMed ID: 2177486
[TBL] [Abstract][Full Text] [Related]
49. Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract.
Lehn H; Villa LL; Marziona F; Hilgarth M; Hillemans HG; Sauer G
J Gen Virol; 1988 Jan; 69 ( Pt 1)():187-96. PubMed ID: 2826665
[TBL] [Abstract][Full Text] [Related]
50. Serum antibodies to the major HSV-2-specified DNA-binding protein in patients with an acute HSV infection or cervical neoplasia.
Lehtinen M; Lehtinen T; Koivisto V; Paavonen J; Leinikki P
J Med Virol; 1985 Jul; 16(3):245-56. PubMed ID: 2993495
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus (HPV) infection of cervical lesions detected by immunohistochemistry and in situ hybridization.
Hoepfner I; Löning T
Cancer Detect Prev; 1986; 9(3-4):293-301. PubMed ID: 3017555
[TBL] [Abstract][Full Text] [Related]
52. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report.
Bavin PJ; Giles JA; Deery A; Crow J; Griffiths PD; Emery VC; Walker PG
Br J Cancer; 1993 Mar; 67(3):602-5. PubMed ID: 8382513
[TBL] [Abstract][Full Text] [Related]
53. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear.
Burk RD; Kadish AS; Calderin S; Romney SL
Am J Obstet Gynecol; 1986 May; 154(5):982-9. PubMed ID: 3010725
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of genital HPV infections in a regularly screened population in The Netherlands in relation to cervical cytology.
Melchers WJ; Herbrink P; Quint WG; Walboomers JM; Meijer CJ; Lindeman J
J Med Virol; 1988 May; 25(1):11-6. PubMed ID: 2842442
[TBL] [Abstract][Full Text] [Related]
55. [Detection of various papilloma virus types in cytologic smears of precancerous conditions and cancers of the uterine cervix].
Wagner D; de Villiers EM; Gissmann L
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):226-31. PubMed ID: 2989076
[TBL] [Abstract][Full Text] [Related]
56. [Foundations for differential cytology of cervical changes. 3. Dysplasia and carcinoma in situ (author's transl)].
Höffken H; Rummel HH
Zentralbl Gynakol; 1981; 103(24):1517-36. PubMed ID: 7340303
[TBL] [Abstract][Full Text] [Related]
57. Relation of herpesvirus type 2 to carcinoma of the cervix.
Rawls WE; Kaufman RH; Gardner HL
Clin Obstet Gynecol; 1972 Dec; 15(4):919-28. PubMed ID: 4346320
[No Abstract] [Full Text] [Related]
58. Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study.
de Villiers EM; Wagner D; Schneider A; Wesch H; Munz F; Miklaw H; zur Hausen H
Gynecol Oncol; 1992 Jan; 44(1):33-9. PubMed ID: 1309717
[TBL] [Abstract][Full Text] [Related]
59. SIGNIFICANCE OF DIFFERENTIAL CELL COUNT OF SMEARS IN THE DIAGNOSIS OF CARCINOMA IN SITU AND ANAPLASIA (ATYPICAL HYPERPLASIA, DYSPLASIA) OF THE UTERINE CERVIX. I. FOUR COMPONENTS OF EXFOLIATED ABNORMAL CELLS IN SMEARS.
OKAGAKI T
J Jpn Obstet Gynecol Soc; 1964 Jan; 11():17-22. PubMed ID: 14197084
[No Abstract] [Full Text] [Related]
60. Specific human papillomavirus types as the causal agents of most cervical intraepithelial neoplasia: implications for current views and treatment.
Kiviat NB; Koutsky LA
J Natl Cancer Inst; 1993 Jun; 85(12):934-5. PubMed ID: 8388477
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
